## RPD: Rapid7, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.30 indicates fundamental undervaluation. Quality metrics strong (ROE 37%). Consistent execution (3/4 quarters beat estimates). Caution: momentum weakening (-6.2% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($14.48)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Rapid7 unwraps new SantaStealer malware-as-a-service**
- Source: SC Media | 20251216T130844 | Bullish | Relevance: 100%
- Rapid7 has detailed SantaStealer, a new malware-as-a-service (MaaS) planned for release this holiday season, which was formerly known as BluelineStealer. This MaaS, advertised on Telegram and cybercrime forums, is designed to exfiltrate sensitive data including credentials, cryptocurrency information, and documents, despite its developers' claims of being "fully undetected". Despite some amateurish aspects, SantaStealer is actively developed, including 14 modules, customizable builds, and features like a WinRAR export builder, with Rapid7 recommending caution against unrecognized links and unverified code to prevent infection.

**2. Rapid7 unwraps new SantaStealer malware-as-a-service**
- Source: SC Media | 20251216T130243 | Somewhat-Bullish | Relevance: 100%
- Rapid7 has identified a new malware-as-a-service (MaaS) called SantaStealer, previously BluelineStealer, which is being advertised for release this holiday season. Despite developer claims of being "fully undetected," Rapid7 found samples easily detectable and noted its "amateurish" yet "ambitious" development. The malware, written in C, aims to exfiltrate sensitive data and includes 14 modules, some exploiting a WinRAR vulnerability, and offers customizable builds with tiered pricing.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 8 ($3.90M) |
| Sells | 6 ($0.36M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 54.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (+7.4%)
- Blackrock Inc.: 10.1% (-1.1%)
- Jana Partners Manage: 9.9% (+13.5%)
- UBS Group AG: 4.9% (-28.9%)
- Penserra Capital Man: 4.1% (-1.8%)

### Key Risks

1. Long-term trend broken: trading 26.5% below SMA200.
2. Falling knife pattern: rapid decline without stabilization, catch risk elevated.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.30 indicates undervaluation relative to growth. Quality metrics strong (ROE 37%). Insider buying signal ($3.9M), management confidence. Institutional flow bearish (5 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $1.0B |
| Beta | 0.84 |
| 52W Range | $13.21 - $41.38 |
| Short Interest | 7.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.30 |
| Forward P/E | 7.8 |
| Current P/E | 7.6 |
| YoY Growth | -2.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 7.4% to 1.2% (-6.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.8pp (needs >4.0% for momentum thesis). MRS_5 (-0.9%) diverging from MRS_20 - short-term weakness emerging. Below SMA200 (0.73x), long-term trend not supportive. RSI neutral at 47. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.22% (CS: 52) | Neutral |
| RSI_14 | 47.4 | Neutral |
| MACD Histogram | 0.07 | Bullish |
| vs SMA20 | 1.004x | Above |
| vs SMA50 | 0.956x | Below |
| vs SMA200 | 0.735x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $15.66
- **Stop Loss:** $14.48 (7.5% risk)
- **Target:** $18.02 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 805
- **Position Value:** $12,606.30
- **Portfolio %:** 12.61%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-11 (Est: $0.42)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.46 | $0.57 | +24.9% |
| 2025Q2 | $0.44 | $0.58 | +30.9% |
| 2025Q1 | $0.34 | $0.49 | +42.3% |
| 2024Q4 | $0.50 | $0.48 | -3.4% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*